Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $425.4 million.

  • RxSight's Cash & Current Investments fell 702.01% to $425.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $425.4 million, marking a year-over-year decrease of 702.01%. This contributed to the annual value of $457.7 million for FY2024, which is 8706.0% up from last year.
  • As of Q3 2025, RxSight's Cash & Current Investments stood at $425.4 million, which was down 702.01% from $414.6 million recorded in Q2 2025.
  • Over the past 5 years, RxSight's Cash & Current Investments peaked at $457.7 million during Q4 2024, and registered a low of $81.7 million during Q2 2021.
  • Over the past 5 years, RxSight's median Cash & Current Investments value was $276.9 million (recorded in 2021), while the average stood at $304.7 million.
  • Examining YoY changes over the last 5 years, RxSight's Cash & Current Investments showed a top increase of 18546.11% in 2022 and a maximum decrease of 3211.43% in 2022.
  • Over the past 5 years, RxSight's Cash & Current Investments (Quarter) stood at $294.3 million in 2021, then tumbled by 32.11% to $199.8 million in 2022, then rose by 22.49% to $244.7 million in 2023, then surged by 87.06% to $457.7 million in 2024, then dropped by 7.06% to $425.4 million in 2025.
  • Its last three reported values are $425.4 million in Q3 2025, $414.6 million for Q2 2025, and $430.6 million during Q1 2025.